
Zhi Yuan Mao
Articles
-
Sep 25, 2023 |
frontiersin.org | Guanghua Rong |Hongwei Cheng |Zhi Yuan Mao |Zhi-De Hu
Highlights• All systemic combinations (chemotherapy plus chemotherapy, targeted therapy plus ICI therapy, targeted therapy plus chemotherapy, and targeted plus targeted therapies) significantly improve the objective response rate in patients with aHCC. • The targeted therapy plus ICI therapy showed better therapeutic efficiency in overall survival, progression-free survival, and objective response rate, compared to the monotherapy.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →